Yardley, PA, United States of America

Bradley Alton Ozenberger

This inventor holds 15 USPTO granted patents, plus 1 CIPO patent, primarily in G Protein Coupled Receptors. Top assignees: American Cyanamid Company, Basf Aktiengesellschaft. Active years: 1997-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bradley Alton Ozenberger. Retrieved from https://idiyas.com/inventor/bradley-alton-ozenberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 93.3

 

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 1997-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
G Protein Coupled Receptors
Bioassay
Peptide Binding
Ligand Detection
Receptor Identification
Opioid Receptors
Recombinant Expression
Transformed Yeast
Fusion Proteins
Cell Systems
Expression Vectors
Protein Interaction
15 patents (USPTO):Explore Patents

Title: The Innovative Mind of Bradley Alton Ozenberger

Introduction

Bradley Alton Ozenberger, a notable inventor located in Yardley, PA, has made significant contributions to the field of biotechnology with his remarkable portfolio of 15 patents. His innovative work primarily revolves around bioassays and protein interactions, pushing the boundaries of scientific research.

Latest Patents

Ozenberger's latest patents showcase his expertise in molecular biology and yeast expression systems. One of his key inventions, "Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay," focuses on the development of expression vectors and yeast cells that incorporate heterologous G protein-coupled receptor genes. This invention aims to enhance the sensitivity to receptor activation and transcriptional activation of pheromone-responsive genes without hindering the cell cycle.

Another significant patent involves "Cell systems having specific interaction of peptide binding pairs." This invention presents modified host cells that express heterologous fused proteins and outlines methods for screening test samples with peptide binding activity. These modified host cells comprise fusion proteins paired with transcriptional activation capabilities, enabling the study of complex protein interactions.

Career Highlights

Ozenberger has had an impressive career, contributing his skills to renowned companies such as American Cyanamid Company and BASF Aktiengesellschaft. His extensive experience in these organizations has shaped his innovative approaches and research techniques, enabling him to achieve numerous patents throughout his career.

Collaborations

Throughout his journey as an inventor, Bradley Alton Ozenberger has worked alongside esteemed colleagues Mark Henry Pausch and John Richard Hadcock. This collaboration with seasoned professionals in the industry has undoubtedly contributed to the advancement of his innovative projects.

Conclusion

Bradley Alton Ozenberger stands out as a pioneering inventor whose work in biotechnology continues to influence various scientific fields. With a robust portfolio of patents and a career marked by collaboration and innovation, Ozenberger exemplifies the spirit of creativity that drives advancements in technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…